Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 43.91 M41.77 M38.33 M33.66 M 157.68 M Research & development ———— — Operating income 243.81 M231.59 M226.39 M275.55 M 977.34 M Non-Operating Income, Total 1.4 M-57 K153 K372 K 1.87 M Interest expense, net of interest capitalized 64.01 M64.71 M65.68 M64.14 M 258.54 M Non-Operating Income, excl. Interest Expenses -62.61 M-64.77 M-65.53 M-63.76 M -256.67 M Unusual income/expense ———— — Pretax income 181.21 M166.82 M160.86 M211.26 M 720.15 M Equity in earnings 49.9 M00— — Taxes 45.33 M41.94 M43.34 M51.79 M 182.41 M Non-controlling/minority interest 65 K52 K49 K76 K 242 K After tax other income/expense ———— — Net income before discontinued operations 135.81 M124.83 M117.47 M159.4 M 537.5 M Discontinued operations ———— — Net income 135.81 M124.83 M117.47 M159.4 M 537.5 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 135.81 M124.83 M117.47 M159.4 M 537.5 M Basic earnings per share (Basic EPS) 0.980.910.841.13 3.86 Diluted earnings per share (Diluted EPS) 0.970.90.831.13 3.83 Average basic shares outstanding 139.03 M137.52 M140.32 M141.6 M — Diluted shares outstanding 139.93 M138.33 M141.42 M142.69 M — EBITDA 300.78 M288.96 M281.66 M332.96 M 1.2 B EBIT 238.22 M222.28 M211.88 M258.18 M 930.55 M Cost of revenue 810 M829.79 M792.55 M799.85 M 3.23 B Other cost of goods sold ———— — Depreciation & amortization (cash flow) 62.57 M66.68 M69.78 M74.78 M 273.81 M